151 related articles for article (PubMed ID: 11594578)
1. Survival of patients with cutaneous T cell lymphoma after treatment with extracorporeal photochemotherapy: a retrospective single-center analysis.
Wollina U; Liebold K; Kaatz M; Looks A; Stuhlert A; Lange D
Ann N Y Acad Sci; 2001 Sep; 941():217-9. PubMed ID: 11594578
[No Abstract] [Full Text] [Related]
2. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
3. U.K. national audit of extracorporeal photopheresis in cutaneous T-cell lymphoma.
Sanyal S; Child F; Alfred A; Callaghan T; Alband N; Whittaker S; Cowan R; Parry E; Robinson S; Dunnill MGS; Wain M; Morris S; Malladi R; Tahir S; Howles A; Arumainathan A; Azurdia R; Grant-Casey J; Matin RN; Gilson D; Howell C; El-Gheriani K; Taylor P; Scarisbrick J
Br J Dermatol; 2018 Feb; 178(2):569-570. PubMed ID: 28782100
[No Abstract] [Full Text] [Related]
4. Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
Ann N Y Acad Sci; 2001 Sep; 941():210-3. PubMed ID: 11594576
[No Abstract] [Full Text] [Related]
5. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
[TBL] [Abstract][Full Text] [Related]
6. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
7. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH
J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954
[TBL] [Abstract][Full Text] [Related]
9. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
[TBL] [Abstract][Full Text] [Related]
10. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.
Heald P; Rook A; Perez M; Wintroub B; Knobler R; Jegasothy B; Gasparro F; Berger C; Edelson R
J Am Acad Dermatol; 1992 Sep; 27(3):427-33. PubMed ID: 1401279
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience.
Jiang SB; Dietz SB; Kim M; Lim HW
Photodermatol Photoimmunol Photomed; 1999 Oct; 15(5):161-5. PubMed ID: 10540936
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma.
Rubegni P; De Aloe G; Fimiani M
Br J Dermatol; 2000 Oct; 143(4):894-6. PubMed ID: 11069483
[No Abstract] [Full Text] [Related]
13. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
Duvic M; Chiao N; Talpur R
J Cutan Med Surg; 2003; 7(4 Suppl):3-7. PubMed ID: 12958700
[No Abstract] [Full Text] [Related]
14. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma.
Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941
[No Abstract] [Full Text] [Related]
15. Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.
Siakantaris MP; Tsirigotis P; Stavroyianni N; Argyropoulos KV; Girkas K; Pappa V; Chondropoulos S; Papadavid E; Sakellari I; Anagnostopoulos A; Antoniou C; Dervenoulas J
Transfus Apher Sci; 2012 Apr; 46(2):189-93. PubMed ID: 22178592
[TBL] [Abstract][Full Text] [Related]
16. [Interferon alpha in the treatment of cutaneous T-cell lymphoma].
Dréno B
Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S27-30. PubMed ID: 16385896
[No Abstract] [Full Text] [Related]
17. Photopheresis for the treatment of cutaneous T cell lymphoma.
Armus S; Keyes B; Cahill C; Berger C; Crater D; Scarborough D; Klainer A; Bisaccia E
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):898-902. PubMed ID: 2147701
[TBL] [Abstract][Full Text] [Related]
18. Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment.
Altomare G; Capella GL; Frigerio E
Acta Derm Venereol; 1998 Mar; 78(2):159. PubMed ID: 9534907
[No Abstract] [Full Text] [Related]
19. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy.
Zic JA; Stricklin GP; Greer JP; Kinney MC; Shyr Y; Wilson DC; King LE
J Am Acad Dermatol; 1996 Dec; 35(6):935-45. PubMed ID: 8959953
[TBL] [Abstract][Full Text] [Related]
20. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma.
Zackheim HS
J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
